It’s possible to achieve population or herd immunity from COVID-19 if we can drive the post-vaccination boosting immunity to levels that would prevent spread.
is past president and director of Fred Hutchinson Cancer Research Center, and a professor of medicine and virology at University of Washington. He is the leader of the COVID-19 Prevention Network (CoVPN) Operations Center, which was formed by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health to respond to the global pandemic, and the chair of the NIH ACTIV COVID-19 Vaccine Clinical Trials Working Group.
COVID-19 is disrupting our gatherings and replacing joyful hugs with masks and physical distance. This year, the glitter of the holidays comes from the scientific...